Drug GMP Warning Letter Downtrend Accelerates in FY 2003

The number of FDA GMP warning letters fell to 29 in fiscal 2003 from 58 the previous year. Factors that may be at work include the agency’s new centralized clearance process and the diversion of FDA attention to other high-risk enforcement concerns.